Drug Discovery World

MAY 22, 2023

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. Clarivate’s ‘Biopharma Dealmaking in 2023’ report examines how pharma companies are replenishing their pipelines as many face a steep patent cliff.

Pharma Companies 130

Pharma Companies RNA Therapies Virus 130

Drug Discovery World

MARCH 14, 2024

Roche and Johnson & Johnson are the only pharma companies to feature in Clarivate’s 2024 list of Top 100 Global Innovators, which highlights organisations leading the world in technology research and innovation. This is the first year that Clarivate is ranking, rather than just listing, the top innovators.

Pharma Companies 130

Pharma Companies Research Drugs 130

Drug Discovery World

DECEMBER 6, 2023

Criticism from the pharma industry In October, over 20 pharma companies rejected the proposed changes to the Statutory Scheme. The main concern was an arbitrary cap on growth in the UK branded medicines market, which has led to revenue clawbacks in the UK rising from around 5% to 27% in just three years.

Government 147

Government Pharma Companies Science International 147

Drug Discovery World

APRIL 27, 2023

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Disease 130

Disease Pharma Companies Science Drugs 130

Drug Discovery World

APRIL 27, 2023

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. You can listen below, or find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Disease 130

Disease Pharma Companies Science Drugs 130

Drug Discovery World

AUGUST 3, 2023

In the first article, Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. ” and “ Why a recent advancement is a giant leap for human genomics ”.

Pharma Companies 130

Pharma Companies Science Drugs DNA 130

Drug Discovery World

AUGUST 3, 2023

In the first article, Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. ” and “ Why a recent advancement is a giant leap for human genomics ”.

Pharma Companies 130

Pharma Companies Science Drugs 130

BioPharma Drive: Drug Pricing

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies 98

Pharma Companies Research Treatment Disease 98

Drug Discovery World

FEBRUARY 5, 2024

The new data was released by pharma company Clinigen to mark the start of Rare Disease Month. However, two-thirds (68%) of patients are comfortable receiving medicines before they’re licensed through their country’s healthcare system.

Disease 130

Disease Pharma Companies Licensing Licensing 130

BioPharma Drive: Drug Pricing

DECEMBER 12, 2023

The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.

Vaccine 73

Vaccine Pharma Companies Virus 73

Drug Patent Watch

JULY 25, 2023

In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the… The post Filing Strategies for Maximizing Pharma Patents appeared first on DrugPatentWatch - Make Better Decisions.

Pharma Companies 98

Pharma Companies 98

Drug Discovery World

OCTOBER 18, 2022

The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. The group are now calling for all those interested – including research organisations, investigators, pharma companies, and patient groups – to get involved.

Clinical Trials 130

Clinical Trials Trials Pharma Companies Science 130

Drug Patent Watch

SEPTEMBER 17, 2023

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the… The post Which pharma companies have the most supplementary protection certificates?

Pharma Companies 59

Pharma Companies Pharmaceuticals Drugs 59

Drug Discovery World

OCTOBER 12, 2023

Our collaboration with BioMap further underscores Sanofi’s commitment to becoming the first pharma company powered by AI at scale.” The post Collaboration to develop AI modules for biotherapeutics appeared first on Drug Discovery World (DDW).

Pharma Companies 130

Pharma Companies Engineering Science Drug Development 130

Drug Discovery World

JANUARY 26, 2024

The convergence of AI with bioengineering technologies like the patient-on-a-chip system is setting a new standard, offering a more accurate, cost-effective and efficient approach to drug discovery, ultimately accelerating the delivery of life-saving drugs to the market.”

Clinical Trials 130

Clinical Trials Trials Animal Testing Pharma Companies 130

Drug Discovery World

JANUARY 25, 2024

Japan-based pharma company Kyowa Kirin has successfully completed the acquisition of gene therapy developer Orchard Therapeutics.

Pharma Companies 130

Pharma Companies Therapies Treatment Disease 130

Fierce BioTech

OCTOBER 25, 2023

The AI innovation race is on: Here are three strategies to ensure you’re not left behind | Biotech and pharma companies are using generative AI to improve business operations, marketing performance and research.

Pharma Companies 64

Pharma Companies Marketing Research 64

Fierce BioTech

OCTOBER 3, 2023

Discover how a top 10 pharma company is making strides in addressing this disparity by harnessing the power of H1's diversity insights to build an equitable clinical trial for cardiovascular disease.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Disease 52

Drug Discovery World

SEPTEMBER 15, 2023

The headlines: Pharma must embrace an AI future says new report Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com.

Pharma Companies 130

Pharma Companies Drugs RNA Vaccine 130

Fierce BioTech

FEBRUARY 13, 2024

Streamlining Compliance: Outsourcing combined services and technology in pharmacovigilance and regulatory affairs Biotech and pharma companies are already tapping into the benefits of outsourcing. dfarris Tue, 02/13/2024 - 12:20 Biotech and pharma companies are already tapping into the benefits of outsourcing.

Compliance 40

Compliance Pharma Companies 40

BioPharma Drive: Drug Pricing

SEPTEMBER 25, 2023

Novartis has made a large investment in targeted radiotherapies, sparking competition from fellow pharma companies and young biotechs.

Pharma Companies 55

Pharma Companies Drugs 55

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. According to the Association of the British Pharmaceutical industry (ABPI), the “radical plans” are “unworkable”.

Government 130

Government Pharma Companies Science Pharmaceuticals 130

Drug Discovery World

FEBRUARY 23, 2023

Spanish pharma company Ferrer and Swiss biotech Asceneuron have signed a licensing agreement giving Ferrer the rights to ASN90 in progressive supranuclear palsy (PSP), an orphan, tau-related disease with a high unmet medical need.

Licensing 130

Licensing Licensing Pharma Companies Drugs 130

Drug Discovery World

JULY 3, 2023

Despite access to this kind of initial support, company founders need tenacity to ensure their company has enough financial backing. It’s about perseverance and listening to the feedback from investors, advisors and pharma companies,” Naval adds. Therefore, one of the most important attributes is persistence.

Science 130

Science Pharma Companies Marketing Virus 130

The Pharma Data

DECEMBER 20, 2020

SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology. UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. .

Clinical Trials 52

Clinical Trials Pharma Companies Vaccine Trials 52

Drug Discovery World

DECEMBER 12, 2022

The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies. .

Pharma Companies 130

Pharma Companies Drugs Clinical Trials Research 130

Fierce BioTech

JULY 25, 2023

But despite the supportive landscape for rare disease therapies, pharma companies still struggle to launch on time, if at all. But despite the supportive landscape for rare disease therapies, pharma companies still struggle to launch on time, if at all.

Pharma Companies 52

Pharma Companies Government Therapies Disease 52

BioPharma Drive: Drug Pricing

JULY 10, 2023

The pharma company will pay $30 million upfront to gain rights to an experimental therapy meant to enhance the anti-tumor effect of radiation.

Licensing 55

Licensing Licensing Pharma Companies Treatment 55

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. Biotech and AI companies founded by purely tech professionals often opt to bring in pharma executives with insider knowledge further down the line.

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Drug Discovery World

NOVEMBER 11, 2022

Pharma companies team-up to reduce emissions . Seven pharmaceutical companies have announced a joint initiative to reduce near-term emissions and help develop net zero health systems. . . . . .

Pharma Companies 130

Pharma Companies Drugs Pharmaceutical Companies Disease 130

H1 Blog

MAY 11, 2023

Omnichannel engagement for physician marketing is a powerful tool for biotechnology and pharma companies looking to increase reach and drive engagement among HCPs. By taking a tailored approach, pharma companies can ensure they’re offering meaningful information that resonates with each individual HCP.

Pharma Companies 52

Pharma Companies Marketing Treatment Pharmaceuticals 52

BioPharma Drive: Drug Pricing

JULY 18, 2023

The pharma company, which will soon split off its generic drug unit, plans to repurchase up to $15 billion of its shares through the end of 2025.

Pharma Companies 52

Pharma Companies Drugs 52

Drug Patent Watch

SEPTEMBER 18, 2022

This chart shows the drug companies with the most supplementary protection certificates (SPCs). The post Which pharma companies have the most supplementary protection certificates? SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the….

Pharma Companies 52

Pharma Companies Pharmaceuticals Drugs 52

thought leadership

JUNE 26, 2023

Customer perception and satisfaction play a pivotal role in shaping the success and reputation of pharma companies. Given the significance of these factors, it's understandable that many pharma companies are deeply interested in conducting patient and healthcare provider (HCP) satisfaction surveys.

Pharma Companies 40

Pharma Companies Production 40

Drug Patent Watch

FEBRUARY 2, 2021

In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. DrugPatentWatch was featured in a recent article by Inc. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.

Pharma Companies 103

Pharma Companies Drugs 103

thought leadership

MAY 29, 2023

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases , cancer, and other complex conditions. In this blog post, we'll explore some of the key challenges of specialty pharma drug development project management and discuss strategies for overcoming them.

Drug Development 52

Drug Development Pharma Companies Drugs Disease 52

PPD

JULY 13, 2023

Data from the survey has produced enlightening insights about the priorities of both large and small/mid-size pharma companies that can be used to guide business decisions. Patient diversity and site capacity issues emerge as key challenges for recruitment vendors to address.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52